---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-038630"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2026-05-28T13:01:18+00:00"
generated_at: "2026-05-28T13:04:22.570135+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology director Saira Ramasastry resigns; board shrinks to 7; annual meeting elects directors

## Summary
- Saira Ramasastry steps down from board and audit committee effective May 26, 2026, due to business conflict; no disagreement with company.
- Robert More appointed Audit Committee Chair; board size reduced from 8 to 7 upon Ramasastry's departure.
- At May 26 annual meeting, Class I directors Robert More, Janet Napolitano, and Elliott Sigal elected; Napolitano received 67.2M for, 54.5M withheld.
- Advisory vote on named executive officer compensation approved: 108.5M for, 11.9M against, 1.4M abstain.
- Ratification of Ernst & Young as independent auditor for FY2026 approved: 137.0M for, 0.15M against.

## SEC filing metadata
- accession: 0001628280-26-038630
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2026-05-28T13:01:18+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000162828026038630/0001628280-26-038630-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000162828026038630/vir-20260525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-038630
- JSON: https://secwatch.observer/filing/0001628280-26-038630.json
- Plain text: https://secwatch.observer/filing/0001628280-26-038630.txt

## Source-grounded claims
- claim_id: 305e0fce20
  claim: Saira Ramasastry departed as Director at Vir Biotechnology, Inc..
  evidence_excerpt: On May 25, 2026, Saira Ramasastry, M.S., M.Phil., a member of the Board of Directors (the Board) of Vir Biotechnology, Inc. (the Company) and Chair of the Company’s Audit Committee (the Audit Committee), informed the Company that, due to a business conflict, she will be stepping down from her role as a member of the Board and the Audit Committee, effective May 26, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000162828026038630/0001628280-26-038630-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.